Panobinostat is a De-acetylator inhibitor for Histone, meaning that it paralyzes a few enzymes perinuclearly, therefore blocking Mitosis this way.
It has demonstrated Activity in Relapsed/Refractory Hodgkin's disease post transplantation. An area where it does not have much competition. And here it is actually pretty good at achieving like most target therapies a 30% effectiveness and with additional stable diseases. A respectable effectiveness.
Now it is being tried in Non Hodgkin's disease with Rituxan. We will update you on this!
A blog about research, awareness, prevention, treatment and survivorship of Breast Cancer and all cancers, including targeted scientific research and a grassroots approach to increase screening for cancer, especially in the low income and under-insured population of El Paso, Texas, with a view to expand this new health care model to many other 'minority' populations across the United States and beyond
Showing posts with label effectiveness. Show all posts
Showing posts with label effectiveness. Show all posts
Friday, January 18, 2013
Subscribe to:
Posts (Atom)